2018-01-30
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study
Publication
Publication
Leukemia p. 1- 4
Additional Metadata | |
---|---|
doi.org/10.1038/s41375-018-0024-1, hdl.handle.net/1765/104934 | |
Leukemia | |
Organisation | Department of Hematology |
Bringhen, S., Mina, R., Cafro, A.M. (Anna Maria), Liberati, A. M., Spada, S. (Stefano), Belotti, A. (Angelo), … Boccadoro, M. (2018). Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. Leukemia, 1–4. doi:10.1038/s41375-018-0024-1 |